This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Kilroy Realty (KRC) Soars 6.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Kilroy Realty (KRC) was a big mover last session on higher-than-average trading volume.
Physicians Realty Trust (DOC) Q4 FFO Match Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 0.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Misses Q3 FFO and Revenue Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of -3.70% and 0.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Piedmont Office (PDM) Q3 FFO Match Estimates
by Zacks Equity Research
Piedmont Office (PDM) delivered FFO and revenue surprises of 0% and 4.47%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Community Healthcare Trust (CHCT) Tops Q3 FFO and Revenue Estimates
by Zacks Equity Research
Community Healthcare Trust (CHCT) delivered FFO and revenue surprises of 6.78% and 1.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
VICI Properties Inc. (VICI) Q3 FFO Meet Estimates
by Zacks Equity Research
VICI Properties Inc. (VICI) delivered FFO and revenue surprises of 0% and 1.54%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Matches Q2 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 0.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Surpasses Q2 FFO Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 5.41% and 2.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Pebblebrook Hotel (PEB) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Pebblebrook Hotel (PEB) delivered FFO and revenue surprises of 5.88% and 5.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Physicians Realty (DOC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Physicians Realty (DOC) stock based on the movements in the options market lately.
Physicians Realty Trust (DOC) Lags Q1 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of -3.57% and 2.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Public Storage (PSA) Tops Q1 FFO and Revenue Estimates
by Zacks Equity Research
Public Storage (PSA) delivered FFO and revenue surprises of 1.67% and 0.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Q4 FFO Match Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 2.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
DiamondRock Hospitality (DRH) Matches Q4 FFO Estimates
by Zacks Equity Research
DiamondRock Hospitality (DRH) delivered FFO and revenue surprises of 0% and 5.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
W.P. Carey (WPC) Tops Q4 FFO and Revenue Estimates
by Zacks Equity Research
W.P. Carey (WPC) delivered FFO and revenue surprises of 4% and 13.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Douglas Emmett (DEI) Meets Q4 FFO Estimates
by Zacks Equity Research
Douglas Emmett (DEI) delivered FFO and revenue surprises of 0% and 14.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Brandywine Realty Trust (BDN) Meets Q4 FFO Estimates
by Zacks Equity Research
Brandywine Realty Trust (BDN) delivered FFO and revenue surprises of 0% and 0.99%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Meets Q3 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0.00% and 0.90%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Misses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of -3.70% and -0.61%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Meets Q1 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0.00% and 0.35%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Physicians Realty Trust (DOC) Meets Q4 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0.00% and 1.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Life Science, MOBs Aid Healthcare REIT Recovery in 2021?
by Devyani Chamria
While seniors housing exposure has crippled healthcare REITs' performance, medical office buildings and life science real estate have emerged more resilient and are grabbing investor attention.
REITs' Q3 Earnings Lined Up for Nov 6: VTR, DOC and CLNY
by Moumita C. Chattopadhyay
The economic disruption and its impact have been widely varied across different property types and thus, delving deeper into each REIT's asset fundamentals and markets becomes all the more important.
Here's Why Prologis is a Promising Investment Bet Right Now
by Zacks Equity Research
Prologis (PLD) stock is an attractive investment option at the moment given its solid prospects and healthy operating performance.
Physicians Realty Trust (DOC) Upgraded to Buy: Here's Why
by Zacks Equity Research
Physicians Realty Trust (DOC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.